CRF Health, a global provider of eCOA solutions for the life sciences industry, has acquired Entra Health, a global leader in mobile health IT, cloud-based remote monitoring, health data exchange and analytics solutions.

The acquisition expands CRF Health’s offerings into the expanding market of wireless medical and wellness devices, bringing a new level of connectivity to its eCOA technologies and establishing a complete network of solutions to collect, manage and analyze biometric and clinical trial data. The combination solidifies CRF Health as an established provider of market-leading eCOA solutions and medical devices for remote patient monitoring, telemedicine and wireless health, backed by unrivalled expertise and regulatory know-how.

The acquisition formalizes an existing relationship, enabling both companies to bring their solutions to customers as an end-to-end integrated offering. Headquartered in San Diego, California, Entra Health offers EntraCare, the most flexible and scalable remote monitoring solution on the market today. EntraCare has regulatory approval and is used by patients in more than 50 countries worldwide. Entra Health’s FDA-cleared MyHealthPoint platform provides an integrated, secure and scalable system for collecting and analyzing biometric data across a variety of wellness and clinical devices. It delivers remote monitoring of clinical trial and non-trial patient populations across a multitude of therapeutic areas as well as post-surgical, preventative and chronic care. The company also manufactures the MyGlucoHealth brand of wireless blood glucose meters, and is an international market leader in supplying wireless glucose monitoring for clinical trials in diabetes research.

“This acquisition represents a significant step in our growth and enables us to deliver our solutions to a wider market with the backing of CRF Health’s global infrastructure,” comments Richard Strobridge, CEO & co-founder of Entra Health. “The combination of the two companies will bring new opportunities for Entra Health’s talented team and will allow us to strengthen our operational capabilities and invest in enhancing our technology and solutions into the future. Our customers benefit from being part of one of the most well-respected names in the industry, bringing a global support network and access to specialized expertise.”

Discussing the acquisition, CRF Health’s CEO, Rachael Wyllie, said, “We see tremendous promise in the opportunities the acquisition of Entra Health brings, as well as the contribution this makes to our continued growth strategy as we broaden CRF Health’s reach across the industry. Combining CRF Health’s extensive global eCOA and electronic informed consent expertise with Entra Health’s clinical platform, medical device innovation and regulatory insight, we can now offer selection, production and delivery of devices together with the complete integration of data. CRF Health is now positioned to build upon our patient-centric approach, bringing new levels of connectivity to devices and cloud services much in demand from our customers.”